Yazar "Caliskaner, A. Zafer" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    B cell aplasia and hypogammaglobulinemia associated with levetiracetam
    (K Faisal Spec Hosp Res Centre, 2018) Ozdemir, Hulya; Sumer, Sua; Karabagli, Hakan; Akdemir, Gokhan; Caliskaner, A. Zafer; Artac, Hasibe
    Levetiracetam (LEV) is a second-generation antiepileptic drug approved for the treatment of several types of epilepsy. We report a 45-year-old female who developed hypogammaglobulinemia and B cell aplasia during LEV treatment. The Naranjo probability score for an adverse drug reaction was 6. After LEV discontinuation, the number of B cells gradually increased and reached normal levels within two months. This case suggests that monitoring of immunoglobulin levels and lymphocyte subsets analysis is important in patients treated with LEV, especially in cases of prolonged infections.
  • Küçük Resim Yok
    Öğe
    A CASE WITH ABSENCE OF B LYMPHOCYTES
    (Springer/Plenum Publishers, 2014) Ozdemir, Hulya; Artac, Hasibe; Ural, Onur; Karabagli, Hakan; Caliskaner, A. Zafer
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    Primary immunodeficiency masquerading the diagnosis of chronic lymphocytic leukemia: a case of selective immunoglobulin A deficiency
    (Bilimsel Tip Yayinevi, 2015) Arslan, Sevket; Ucar, Ramazan; Caliskaner, A. Zafer
    The awareness of the probability of primary immunodeficiency in adults has been increased. However, careful differential diagnosis is necessary before a final diagnosis of primary immunodeficiency is made. In this report, a patient with a preliminary diagnosis of primary immunodeficiency due to recurrent pulmonary infections and selective IgA deficiency who was finally diagnosed as chronic lymphocytic leukemia was presented.